MTHFR T677 homozygosis influences the presence of aura in migraineurs

Cephalalgia

Volumn 24, Issue 6, 2004, Pages 491-494

  Oterino, A ^a   Valle, N ^a   Bravo, Y ^a   Munoz P ^a   Sanchez Velasco P ^a   Ruiz Alegria C ^a   Castillo, J ^a   Leyva Cobian F ^a   Vadillo, A ^a   Pascual, J ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

10 methylenetetrahydrofolate reductase (MTHFR); 5 ; Folate metabolism; Migraine with aura

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GENE FREQUENCY; HOMOZYGOTE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; ODDS RATIO;

EID: 2942579083     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00692.x     Document Type: Article

References (22)

1. 2+ channel gene CACNL1A4. Cell 1996; 87:543-52.
2. + pump α2 subunit with familial hemiplegic migraine type 2. Nat Genet 2003; 33:192-6.
3. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K, et al. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet (Neuropsychiatr Genet) 2000; 96:762-764.
4. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphism in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Mol Brain Res 2003; 111:84-90.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalagia 1988; 8 Suppl 7:1-96.
6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA et al. A candidate genetic risk factor for vascular disease: a common mutation to methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-3.
7. Shimomura T, Kitano A, Marukawa H, Takahashi K. Mutation in platelet mitochondrial gene in patients with migraine. Cephalalgia 1995; 15:10.
8. Hann J, Terwindt GM, Maassen JA, Hart LM, Frants RR, Ferrari MD. Search for mitochondrial DNA mutation in migraine subgroup. Cephalalgia 1999; 19:20-2.
9. Russell MB, Diamant M, Norby S. Genetic heterogeneity of migraine with and without aura in Danes cannot be explained by mutation in mtDNA nucleotide pair 11084. Acta Neurol Scand 1997; 96:171-3.
10. Goadsby PJ. Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol 2001; 49:4-6.
11. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90:1-11.
12. Kopjas TL. The use of folic acid in vascular headache of the migraine type. Headache 1969; 8:167-70.
13. Dalsgaard-Nielsen T, Trautmann J. Prophylactic treatment of migraine with vitamin B12. Ugeskr Laeger 1970; 132:339-41.
14. Van der Kuy PH, Merkus FW, Lohman JJ, ter Berg JW, Hooymans PM. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study. Cephalalgia 2002; 22:513-9.
15. Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994; 14:328-9.
16. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology 1998; 50:466-70.
17. 1B/1D agonists inhibits trigeminal cell firing in the cat. Brain 1997; 120:2171-7.
18. Evers S, Koch HG, Husstedt IW. Plasma homocysteine levels in primary headache. In: Olesen J, Edvinsson L, editors. Headache Pathogenesis: Monoamines, Neuropeptides, Purines and Nitric Oxide. Philadelphia: Lippincott-Raven Publishers, 1997:215-8.
19. Hering-Hanit R, Gadoth N, Yavetz A, Gavendo S, Sela B. Is blood homocysteine elevated in migraine? Headache 2001; 41:779-81.
20. Carolei A, Marini C, De Matteis G and the Italian National Research Council Study Group on Stroke in the Young. History of migraine and risk of cerebral ischemia in young adults. Lancet 1996; 347:1503-6.
21. Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997; 54:362-8.
22. Chang CI, Donaghy M, Poulter N. and World Health Organisation Collaborative Study in Cardiovascular disease and Steroid Hormone Contraception. Br Med J 1999; 318:13-8.